Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Poseida Therapeutics Inc.

    NASDAQ: PSTX · Real-Time Price · USD
    9.50
    0.00 (0.00%)
    At close: Jan 07, 2025, 10:00 PM

    Poseida Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 64.7M 130.36M 31.24K
    Cost of Revenue
    		 156.77M 5.17M 4.55M
    Gross Profit
    		 -92.07M 125.19M -4.52M
    Operating Income
    		 -129.5M -59.95M -141.41K
    Interest Income
    		 n/a n/a 3.36M
    Pretax Income
    		 -123.32M -63.46M -124.97K
    Net Income
    		 -123.43M -64M 4.4M
    Selling & General & Admin
    		 37.44M 37.54M 35.91K
    Research & Development
    		 156.77M 152.9M 136.73K
    Other Expenses
    		 n/a 2.86M 19.8K
    Operating Expenses
    		 194.21M 190.44M 172.65K
    Interest Expense
    		 8.67M 6.37M 3.36K
    Selling & Marketing Expenses
    		 n/a n/a n/a
    Cost & Expenses
    		 179.35M 190.44M 172.65K
    Income Tax Expense
    		 107K 544K -4.53M
    Shares Outstanding (Basic)
    		 90.19M 71.91M 62.18M
    Shares Outstanding (Diluted)
    		 90.19M 71.95M 62.24M
    EPS (Basic)
    		 -1.37 -0.89 0.07
    EPS (Diluted)
    		 -1.37 -0.89 0.07
    EBITDA
    		 -109.04M -54.77M -117.06M
    EBIT
    		 -114.65M -57.09M -121.62M
    Depreciation & Amortization
    		 5.61M 5.17M 4.55M

    Add to Watchlist